How many insider trades does FilingIQ track for LUNG?

FilingIQ tracks 391 Form 4 insider transactions for LUNG (Pulmonx Corp), covering filings from Aug 29, 2018 onwards. 18 of those were filed in the last 90 days.

Are LUNG insiders net buyers or net sellers?

Across the full Form 4 history for LUNG, 11 transactions (3%) were open-market purchases and 281 (72%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does LUNG insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is LUNG in?

Pulmonx Corp (LUNG) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $59.40M.

LUNG insider trading

NasdaqGS Healthcare

Pulmonx Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

391

Last 90 days

Buys / sells

3% / 72%

Market cap

$59.40M

About Pulmonx Corp

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Company website: pulmonx.com

LUNG insider activity at a glance

FilingIQ has scored 391 insider transactions for LUNG since Aug 29, 2018. The most recent filing in our index is dated Mar 2, 2026.

Across the full history, 11 open-market purchases and 281 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on LUNG insider trades is 54.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live LUNG trades on FilingIQ Raw filings on SEC EDGAR

Latest LUNG Form 4 filings

French Glendon E. III President and CEO

S Mar 2, 2026

Joshi Mehul Chief Financial Officer & PAO

S Mar 3, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for LUNG?: FilingIQ tracks 391 Form 4 insider transactions for LUNG (Pulmonx Corp), covering filings from Aug 29, 2018 onwards. 18 of those were filed in the last 90 days.
Are LUNG insiders net buyers or net sellers?: Across the full Form 4 history for LUNG, 11 transactions (3%) were open-market purchases and 281 (72%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does LUNG insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is LUNG in?: Pulmonx Corp (LUNG) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $59.40M.

Methodology & sources

Every LUNG insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.